Besides, the correlation between the miR-181c overexpression after -and possibly induced by- the MAP treatment and the absence of the tumor relapse, can be partially explained considering that among its putative targets figure genes regulating the cell cycle, like GATA6, MAP2K1, PPM1A and Notch2. Here, GATA6 is linked to neoplasm.